Skip to Main content Skip to Navigation
Journal articles

Selenofolate inhibits the proliferation of IGROV1 cancer cells independently from folate receptor alpha

Abstract : Cancer is one of the main causes of human mortality worldwide and novel chemotherapeutics are required due to the limitations of conventional cancer therapies. For example, using redox selenium compounds as novel chemotherapeutics seem to be very promising. The objective of this study was to explore if folate could be used as a carrier to deliver a newly synthesised selenium derivative selenofolate into cancer cells. Particularly, the cytotoxic effects of this selenofolate compound were investigated in a variety of cancer cell types including lung, liver, and cervical cancers and specifically IGROV1 cells. Our results showed that selenofolate inhibits the growth of cancer cells in-vitro. However, despite the expectations, folate receptor alpha (FRα) was not involved in the transportation of selenofolate compound into the cells i.e. growth inhibition was independent of FRα, suggesting that multiple transporters (e.g. reduced folate carrier-1) are possibly involved in the delivery and internalisation of folate in IGROV1 cells. Additionally, selenofolate did not exert cell death through apoptosis. Instead, anti-proliferative activity showed to be the main cause of growth inhibition of selenolofate in the IGROV1 cell line. In conclusion, selenofolate inhibits the growth of cancer cells and thus, may be explored further as a potential chemotherapeutic agent.
Document type :
Journal articles
Complete list of metadata

https://hal.univ-lorraine.fr/hal-03372748
Contributor : Stephane PARANT Connect in order to contact the contributor
Submitted on : Monday, October 11, 2021 - 10:02:19 AM
Last modification on : Sunday, June 26, 2022 - 3:15:40 AM
Long-term archiving on: : Wednesday, January 12, 2022 - 7:05:19 PM

File

Heliyon 2021 final folate.pdf
Publisher files allowed on an open archive

Licence


Distributed under a Creative Commons Attribution 4.0 International License

Identifiers

Collections

Citation

Ali Razaghi, Antje Maria Zickler, Julian Spallholz, Gilbert Kirsch, Mikael Björnstedt. Selenofolate inhibits the proliferation of IGROV1 cancer cells independently from folate receptor alpha. Heliyon, Elsevier 2021, 7 (6), pp.e07254. ⟨10.1016/j.heliyon.2021.e07254⟩. ⟨hal-03372748⟩

Share

Metrics

Record views

24

Files downloads

27